All the products (3a-p) were newly synthesized and characterized by their spectral analysis. Chemicals, p-chloro, p-amino and p-methoxy acetophenones were purchased from S. D. Fine Chemicals (India). Parent 5-chloro-2-hydroxy acetophenones, 5-methyl-2-hydroxy acetophenone and 5-chloro-4-methyl-2-hydroxy acetophenone were synthesized from p-chloro, p-methyl and 3-methyl-4-chloro phenols, respectively, by the Fries-reaction using acetic anhydride and AlCl 3 (15) . 2-Hydroxy-3-iodo substituted acetophenones were syntesized by our previously reported method (16) . 2-Hydroxy-3-bromo substituted acetophenones were also synthesized by the bromination (bromine in acetic acid) method (15) . 2-Butyl-4-chloro-5-formyl-imidazole was purchased from Sigma-Aldrich (India) and 2-amino-4-(4-chlorophenyl)-5-formyl-thiazole was prepared by the reported method (17) .
EXPERIMENTAL
The title compounds were synthesized by Claisen-Schmidt condensation (15) using PEG-400 as reaction solvent. All the melting points were uncorrected and determined in an open capillary tube. The chemicals and solvents used were of laboratory grade and were purified. Completion of the reaction was monitored by thin layer chromatography on precoated sheets of silica gel-G (Merck, Germany) using iodine vapour for detection. IR spectra were recorded in KBr on a Shimadzu spectrometer (Japan). 1 H NMR spectra were recorded in DMSO-d 6 with an Avance spectrometer (Bruker, Germany) at 300-MHz frequency using TMS as an internal standard. Mass spectra were recorded on an EI-Shimadzu QP 2010 PLUS GC-MS system (Shimadzu, Japan). Elemental analyses were performed on a Carlo Erba 106 Perkin-Elmer model 240 analyzer (Perkin-Elmer, USA).
The synthetic pathway is presented in Scheme 1 and physicochemical data for the synthesized compounds are given Table I .
General procedure for the synthesis of 1-(substituted phenyl), 3-(2-butyl-5-chloro-3H--imidazol-4-yl) or (2-amino-4-(4-chlorophenyl)-thiazol-5-yl)-2-propen-1-ones (3a-p)
An equimolar mixture of substituted acetophenone 1 (1 mmol), aromatic aldehyde 2 (1 mmol) and KOH (2 mmol) was stirred in PEG-400 (15 mL) at 40°C for 1 hour. After completion of the reaction (monitored by TLC), the crude mixture was worked up in ice-cold water (100 mL). The product which separated out was filtered. The filtrate was evaporated to remove water leaving PEG behind. The same PEG was utilized to synthesize further chalcones.
Spectroscopic data for all synthesized compounds are given in Table II .
Antimicrobial activity
All the synthesized compounds (3a-p) were screened for their in vitro antimicrobial activity by the agar diffusion method (18) . Antibacterial activity was checked against the bacteria Escherichia coli, Salmonella typhi, Staphylococcus aureus and Bacillus subtillis. The culture strains of bacteria were maintained on a nutrient agar slant at 37 ± 2°C for 24-48 h. Antifungal activity was studied against Aspergillus niger, Aspergillus flavus, Peni-cillium chrysogenum and Fusarium moneliforme. The results were compared with penicillin and nystatin. All the culture strains of fungi were maintained on a potato dextrose agar (PDA) slant at 27 ± 2°C for 24-28 h, until sporulation. Spores were transferred into 5 mL of sterile distilled water containing 1 % Tween-80 (to suspend the spores properly). The spores were counted with a haemocytometer (10 6 CFU mL -1 ). Sterile PDA plates containing 2 % agar were prepared; 0.1 mL of each fungal spore suspension was spread on each plate and incubated at 27 ± 2°C for 12 h. After incubation, a hole was made using a sterile cork borer and each agar well was filled with 0.1 mL chalcone solution of 50, 100 and 250 mg mL -1 separately to get the minimum inhibitory concentration (MIC) value of chalcones. Dimethyl sulphoxide (DMSO) was used as a solvent for chalcones and as well as a control, while distilled water used as solvent for standard drugs. The plates were kept in refrigerator for 20 minutes for diffusion and then incubated at 27 ± 2°C for 24-28 h in an incubator. After incubation, the zone of inhibition of compounds was measured in mm and standard and minimum inhibitory concentrations (MICs) were noted. The results of antimicrobial studies are given in Table III The Claisen-Schmidt condensation (15) is an important C-C bond formation for the synthesis of 1,3-diaryl-2-propen-1-ones (chalcones). It is generally carried out by the use of strong bases such as NaOH or KOH in polar solvents (MeOH or DMF). The aim of the present study was to develop an efficient protocol using PEG-400 as a recyclable reaction solvent to obtain 1,3-diaryl-2-propen-1-ones with good to excellent yields in a short span of time without formation of any side product. (50) 16 (50) 19 (50) 20 (50) 18 (50) 20 (50) 19 (50) 18 (50) 3f 11 (100) 12 (100) 14 (100) 11 (100) 14 (100) 15 (100) 16 (100) 12 (100) 3g 16 (50) 20 (50) 18 (50) 14 (50) 19 (50) 20 (50) 22 (50) First, we attempted condensation of 2-hydroxy-5-chloro-acetophenone with 2-butyl--4-chloro-5-formyl-imidazole using PEG-400 as a reaction solvent under alkaline conditions. The reaction was completed within 1 h and the corresponding product was obtained in 95 % yield. Encouraged by the results, we turned our attention to a variety of acetophenones and hetero aldehydes. In all cases, the reaction proceeded efficiently in high yields at 40°C using PEG-400 as an alternative reaction solvent.
IR spectra of chalcones showed characteristic bands at 1640-1650 cm -1 due to >C=O stretching vibration. Lowering of normal >C=O frequency was observed due to the presence of -C=C stretching in chalcones. 1 H NMR spectra of the compounds showed characteristic doublet signals at d 7.3 and 7.8 ppm due to alkene a,b-protons, respectively. However, these doublets coalesced with aromatic protons. The phenolic proton (2'-OH) was observed as a singlet at d 11-12.0 ppm due to hydrogen bonding with the adjacent carbonyl group, while other aromatic and aliphatic protons were found at expected regions. 13 All the synthesized compounds were tested for their in vitro antimicrobial activity. The results are given in Table III . Compounds 3c, 3e, 3g, 3j and 3n showed good activity against all tested bacteria at concentration of 50 mg mL -1 . Compounds 3c and 3e showed a maximum zone of inhibition (20 mm) against B. subtillis compared to penicillin. Compounds 3g and 3j showed an effective zone of inhibition (19-20 mm) against S. aureus in comparison with the standard. Compounds 3a, 3d, 3k, 3l, 3m and 3o were found to be less active against the tested bacterial strains (MIC = 100 mg mL -1 ). Antifungal screening data showed that most of the compounds were active against all fungi. Compounds 3c, 3d, 3e, 3g, 3j and 3n showed effective activity against all fungal strains at MIC of 50 mg mL -1 . Compound 3n showed comparabile activity against Aspergillus niger to standard drug, but compounds 3g, 3j and 3n displayed an even stronger zone of inhibition (19-22 mm) against all the tested fungi. On the other hand, compounds 3b, 3h and 3m were found to be inactive against Aspergillus flavus, and compounds 3k, 3l, 3o and 3p exhibited activities comparable to that of nystatin. When structure and activity relationships are investigated, we can infer from the results that halogen at the R 2 position might be responsible for antibacterial and antifungal activity. Furthermore, it can be concluded that in compounds 3g and 3j bearing methyl group at R 3 or R 4 position in combination with Br and I at R 2 , both groups enhanced activity. Further studies of the inhibitory activity of new compounds bearing methyl and halo substituents at different positions against important human pathogenic fungi are under way.
CONCLUSIONS
In conclusion, our protocol is a practical approach which uses PEG as a commercially available, low-cost, recyclable non-ionic solvent. In most cases, the reaction proceeded smoothly to produce the corresponding 1,3-diaryl-2-propen-1-ones. The reaction was clean and the products were obtained in excellent yields without formation of any side products. The substituted chalcone derivatives, 1-(5-chloro-2-hydroxy-3-iodo phenyl), 3-(2-butyl-5-chloro-3H-imidazol-4yl)-2-propen-1-one (3c), 1-(5-chloro-2-hydroxy-4--methyl phenyl), 3-(2-butyl-5-chloro-3H-imidazol-4yl)-2-propen-1-one (3e), 1-(3-bromo--5-chloro-2-hydroxy-4-methyl phenyl), 3-(2-butyl-5-chloro-3H-imidazol-4yl)-2-propen-1--one (3g), 1-(2-hydroxy-3-iodo-5-methyl phenyl), 3-(2-amino-4-(4-chlorophenyl)-thiazol--5-yl)-2-propen-1-one (3j), 1-(3-bromo-5-chloro-2-hydroxy phenyl), 3-(2-amino-4-(4-chlorophenyl)-thiazol-5-yl)-2-propen-1-one (3n) revealed significant antibacterial and antifungal activity. Compound 3n showed activity equivalent to that of the standard against Aspergillus niger. Considering the results obtained from antibacterial and antifungal tests together, it is noteworthy that the tested compounds were found more active towards fungi than bacteria. Opisana je jednostavna i pogodna metoda sinteze novih hetero 1,3-diaril-2-propen--1-ona (kalkona) koriste}i poli(etilenglikol) (PEG-400) kao alternativno otapalo. Reakcija je jednozna~na, a uporaba hlapljivih organskih otapala je smanjena. Iskori{tenja na produktima su visoka, a reakcijska vremena kra}a. Svi sintetizirani spojevi testirani su na antimikrobno djelovanje na nekoliko patogenih mikroorganizama. 
